HSP90AA1 and osteosarcoma: HSP90AA1 increases chemotherapy resistance by promoting autophagy and inhibiting apoptosis, and inhibiting HSP90AA1 restores the sensitivity of osteosarcoma cells to chemotherapy in vitro and in vivo [10].